Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Morphothiadine - HEC Pharm

Next Previous
Drug Profile

Morphothiadine - HEC Pharm

Alternative Names: GLS4; Morphothiadin; Morphothiadine mesilate; Morphothiadine mesylate

Latest Information Update: 04 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator HEC Pharm
  • Class Antivirals; Bromobenzenes; Esters; Fluorinated hydrocarbons; Mesylates; Morpholines; Pyrimidines; Small molecules; Thiazoles
  • Mechanism of Action Hepatitis B virus replication inhibitors; Viral core protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II/III Hepatitis B

Most Recent Events

  • 14 Sep 2023 HEC Pharm completes a phase II trial in Hepatitis B (Combination therapy) in China (PO) (NCT04147208)
  • 12 Mar 2021 Sunshine Lake Pharma completes a phase I trial for Hepatitis B (In volunteers, combination therapy) in China (PO) (NCT04551261)
  • 03 Mar 2021 Phase II development is still ongoing for Hepatitis B (Combination therapy) in China (NCT04147208)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top